Completed NA INTERVENTIONAL 3-arm NCT04242719

Management of Deep Retinal Capillary Ischemia by Electromagnetic Stimulation and Platelet- Rich Plasma (rEMS)

Sponsor: Ankara Universitesi Teknokent

Conditions Acute Macular Neuroretinopathy Deep Retinal Capillary Ischemia Paracentral Acute Middle Maculopathy

Interventions Electromagnetic stimulation Platelet rich plasma

Updated 5 times since 2020 Last updated: Jan 23, 2020 Started: Jan 1, 2018 Primary completion: Jan 30, 2019 Completion: Feb 28, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04242719, this NA trial focuses on Acute Macular Neuroretinopathy and Deep Retinal Capillary Ischemia and remains completed. Sponsored by Ankara Universitesi Teknokent, it has been updated 5 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Feb 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ankara Universitesi Teknokent

Data source: Ankara Universitesi Teknokent

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ankara, Turkey (Türkiye)